Are the senses enough for sense? Early high-level feedback shapes our comprehension of multisensory objects

por Naci, Lorina, Taylor, Kirsten I., Cusack, Rhodri, Tyler, Lorraine K.
Publicado 2012

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor Progression

por Jackson, Holly, Anzures-Cabrera, Judith, Taylor, Kirsten I., Pagano, Gennaro
Publicado 2021

Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging...

por Taylor, Kirsten I., Sambataro, Fabio, Boess, Frank, Bertolino, Alessandro, Dukart, Juergen
Publicado 2018

Outcome measures based on digital health technology sensor data: data- and patient-centric approaches

por Taylor, Kirsten I., Staunton, Hannah, Lipsmeier, Florian, Nobbs, David, Lindemann, Michael
Publicado 2020

Medial perirhinal cortex disambiguates confusable objects

por Kivisaari, Sasa L., Tyler, Lorraine K., Monsch, Andreas U., Taylor, Kirsten I.
Publicado 2012

The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer’s Disease: The Temporal Emergence of Cognitive Decline

por Mistridis, Panagiota, Krumm, Sabine, Monsch, Andreas U., Berres, Manfred, Taylor, Kirsten I.
Publicado 2015

Feature Statistics Modulate the Activation of Meaning During Spoken Word Processing

por Devereux, Barry J., Taylor, Kirsten I., Randall, Billi, Geertzen, Jeroen, Tyler, Lorraine K.
Publicado 2015

Distinct neural systems underlying reduced emotional enhancement for positive and negative stimuli in early Alzheimer's disease

por Mistridis, Panagiota, Taylor, Kirsten I., Kissler, Johanna M., Monsch, Andreas U., Kressig, Reto W., Kivisaari, Sasa L.
Publicado 2014

Self‐Report versus Clinician Examination in Early Parkinson's Disease

por Zolfaghari, Sheida, Thomann, Alessandra E., Lewandowski, Natalia, Trundell, Dylan, Lipsmeier, Florian, Pagano, Gennaro, Taylor, Kirsten I., Postuma, Ronald B.
Publicado 2021

Cats and Apples: Semantic Fluency Performance for Living Things Identifies Patients with Very Early Alzheimer’s Disease

por Krumm, Sabine, Berres, Manfred, Kivisaari, Sasa L, Monsch, Andreas U, Reinhardt, Julia, Blatow, Maria, Kressig, Reto W, Taylor, Kirsten I
Publicado 2020

BrainCheck – a very brief tool to detect incipient cognitive decline: optimized case-finding combining patient- and informant-based data

por Ehrensperger, Michael M, Taylor, Kirsten I, Berres, Manfred, Foldi, Nancy S, Dellenbach, Myriam, Bopp, Irene, Gold, Gabriel, von Gunten, Armin, Inglin, Daniel, Müri, René, Rüegger, Brigitte, Kressig, Reto W, Monsch, Andreas U
Publicado 2014

Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease

por Lipsmeier, Florian, Taylor, Kirsten I., Postuma, Ronald B., Volkova-Volkmar, Ekaterina, Kilchenmann, Timothy, Mollenhauer, Brit, Bamdadian, Atieh, Popp, Werner L., Cheng, Wei-Yi, Zhang, Yan-Ping, Wolf, Detlef, Schjodt-Eriksen, Jens, Boulay, Anne, Svoboda, Hanno, Zago, Wagner, Pagano, Gennaro, Lindemann, Michael
Publicado 2022

Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial

por Lipsmeier, Florian, Taylor, Kirsten I., Kilchenmann, Timothy, Wolf, Detlef, Scotland, Alf, Schjodt‐Eriksen, Jens, Cheng, Wei‐Yi, Fernandez‐Garcia, Ignacio, Siebourg‐Polster, Juliane, Jin, Liping, Soto, Jay, Verselis, Lynne, Boess, Frank, Koller, Martin, Grundman, Michael, Monsch, Andreas U., Postuma, Ronald B., Ghosh, Anirvan, Kremer, Thomas, Czech, Christian, Gossens, Christian, Lindemann, Michael
Publicado 2018

Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease

por Kremer, Thomas, Taylor, Kirsten I., Siebourg‐Polster, Juliane, Gerken, Thomas, Staempfli, Andreas, Czech, Christian, Dukart, Juergen, Galasko, Douglas, Foroud, Tatiana, Chahine, Lana M., Coffey, Christopher S., Simuni, Tanya, Weintraub, Daniel, Seibyl, John, Poston, Kathleen L., Toga, Arthur W., Tanner, Caroline M., Marek, Kenneth, Hutten, Samantha J., Dziadek, Sebastian, Trenkwalder, Claudia, Pagano, Gennaro, Mollenhauer, Brit
Publicado 2021

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data

por Pagano, Gennaro, Boess, Frank G., Taylor, Kirsten I., Ricci, Benedicte, Mollenhauer, Brit, Poewe, Werner, Boulay, Anne, Anzures-Cabrera, Judith, Vogt, Annamarie, Marchesi, Maddalena, Post, Anke, Nikolcheva, Tania, Kinney, Gene G., Zago, Wagner M., Ness, Daniel K., Svoboda, Hanno, Britschgi, Markus, Ostrowitzki, Susanne, Simuni, Tanya, Marek, Kenneth, Koller, Martin, Sevigny, Jeff, Doody, Rachelle, Fontoura, Paulo, Umbricht, Daniel, Bonni, Azad
Publicado 2021